Sven Enerbäck

Title: Sven Enerbäck: Innovator in Protein Complexes and Gene Delivery

Introduction

Sven Enerbäck is a notable inventor based in Molndal, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of protein complexes and gene delivery systems. With a total of 2 patents, Enerbäck's work has the potential to impact medical treatments for various conditions.

Latest Patents

Enerbäck's latest patents include a complex of a human FOXC2 protein and a FOXC2-interacting protein. This invention relates to the complexes of the FOXC2 protein with other proteins, specifically with proteins designated p621, NOLP, HSC71, FTP3, CLH1, and Kinase A Anchor Protein 84/149 (AKAP). These protein complexes can be utilized in methods for identifying agents that may be effective in treating medical conditions associated with modulated FOXC2 activity, such as obesity, hypertriglyceridemia, diet-induced insulin resistance, and type 2 diabetes. Another significant patent involves the targeted delivery of virus vectors to mammalian cells, showcasing his innovative approach to gene therapy.

Career Highlights

Throughout his career, Sven Enerbäck has worked with various companies, including Leangene AB and Got-A-Gene AB. His experience in these organizations has contributed to his expertise in biotechnology and patent development.

Collaborations

Enerbäck has collaborated with notable colleagues, including Isabel Climent-Johansson and Leif Lindholm. These partnerships have likely enhanced his research and development efforts in the field.

Conclusion

Sven Enerbäck's contributions to biotechnology through his patents and collaborations highlight his role as an innovator in the field. His work on protein complexes and gene delivery systems holds promise for advancing medical treatments.